Living Cell Financials

LVCLF Stock  USD 0  0.0009  26.47%   
We recommend to make use of Living Cell Technologies fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of Living Cell Technologies as well as the relationship between them. We were able to break down and interpolate thirty-one available fundamentals for Living Cell, which can be compared to its peers in the industry. The stock experiences a very speculative downward sentiment. The market maybe over-reacting. Check odds of Living Cell to be traded at $0.0024 in 90 days.
  

Living Cell Stock Summary

Living Cell competes with HomeTrust Bancshares, Visa, Douglas Emmett, Invitation Homes, and Hanover Insurance. Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. The company was founded in 1987 and is based in Sydney, Australia. Living Cell operates under Biotechnology classification in the United States and is traded on OTC Exchange.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business AddressTower 2, Sydney,
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.lctglobal.com
Phone61 3 8689 9997
CurrencyUSD - US Dollar

Living Cell Key Financial Ratios

There are many critical financial ratios that Living Cell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Living Cell Technologies reports annually and quarterly.

Living Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Living Cell's current stock value. Our valuation model uses many indicators to compare Living Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Living Cell competition to find correlations between indicators driving Living Cell's intrinsic value. More Info.
Living Cell Technologies is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Living Cell's earnings, one of the primary drivers of an investment's value.

Living Cell Technologies Systematic Risk

Living Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Living Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Living Cell Technologies correlated with the market. If Beta is less than 0 Living Cell generally moves in the opposite direction as compared to the market. If Living Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Living Cell Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Living Cell is generally in the same direction as the market. If Beta > 1 Living Cell moves generally in the same direction as, but more than the movement of the benchmark.

Complementary Tools for Living Pink Sheet analysis

When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.